Plain-English translation of NCT06342414 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing a new blood test that looks for tiny particles called exosomes in your bloodstream to help identify which type of liver cancer you have. This test uses advanced computer analysis to recognize patterns that distinguish between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. The goal is to create a simple, non-invasive way for doctors to diagnose your condition without needing a tissue biopsy.
Currently, doctors often need to perform invasive biopsies—taking a small piece of liver tissue—to definitively determine which type of liver cancer a patient has. This biopsy carries risks of bleeding and other complications. This medication-free test could provide an accurate diagnosis from just a blood draw, making it safer and easier for patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be part of one of two groups—either in the training phase where researchers develop the blood test, or in the validation phase where they test it on new patients. Your main responsibility is to provide a blood sample (which may have already been collected as part of your standard care). The researchers will analyze your blood for the exosomal particles and use computer algorithms to help refine the diagnostic test. There are no ongoing treatments or multiple visits required for this study.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
United States
Japan